-
Cross-linguistic exploration of speech treatment for Parkinson’s disease: is a universal speech treatment approach plausible?
-
CSF inflammatory cytokines and correlation with clinical features in early, untreated PD patients
-
Cultural disparities in deep brain stimulation (DBS) decision making in patients with Parkinson’s disease (PD): Updates
-
Customizing Rehabilitation based on oromotor function assessed with dynamic MRI in early Parkinson’s disease
-
CVT-301 treatment provides consistent and clinically significant improvements in Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) over 12 weeks
-
Cytokines and Brain Specific Antibodies in Experimental Cellular and Molecular Treatment of Huntington’s Diseases
-
Daily Time-Course of Efficacy of Continuous Subcutaneous Infusion of Foslevodopa/foscarbidopa in Advanced Parkinson’s Disease Patients from a Phase 1b Study
-
De novo impulse control disorder after globus pallidus internus deep brain stimulation in a patient with myoclonus-dystonia syndrome
-
De-novo ß-actin mutation as a cause of seemingly sporadic dystonia-deafness syndrome responsive to deep-brain stimulation
-
Decline in the midbrain-to-pons ratio over one year can support the differentiation between PSP and IPD
- « Previous Page
- 1
- …
- 36
- 37
- 38
- 39
- 40
- …
- 149
- Next Page »